Kalvista Pharmaceuticals shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Kalvista Pharmaceuticals (KALV) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Kalvista Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Kalvista Pharmaceuticals held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Kalvista Pharmaceuticals by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $206k | 17k | 12.25 |
| 2023-09-30 | $120k | 13k | 9.63 |
| 2023-06-30 | $113k | 13k | 9.00 |
| 2023-03-31 | $98k | 13k | 7.86 |
| 2022-12-31 | $85k | 13k | 6.76 |
| 2022-09-30 | $181k | 13k | 14.51 |
| 2022-06-30 | $123k | 13k | 9.84 |
| 2022-03-31 | $184k | 13k | 14.74 |
| 2021-12-31 | $81k | 6.1k | 13.23 |
| 2021-09-30 | $107k | 6.1k | 17.45 |
| 2021-06-30 | $147k | 6.1k | 23.98 |
| 2021-03-31 | $158k | 6.1k | 25.69 |
| 2020-12-31 | $135k | 7.1k | 19.03 |
| 2019-06-30 | $139k | 6.3k | 22.15 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors